| Bioactivity | Tuberculosis inhibitor 12 (compound 12) is an oxadiazole derivative and an inhibitor of Mycobacterium tuberculosis. The inhibition rates of Tuberculosis inhibitor 12 (20 μM) on 7H9-Tw-OADC and 7H9-Tw-OADC reached 82% and 78% respectively[1]. |
| Target | Mycobacterium tuberculosis |
| Name | Tuberculosis inhibitor 12 |
| CAS | 793729-44-9 |
| Formula | C15H9FN4O3S |
| Molar Mass | 344.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Early JV, et al. Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2016 May 23;60(6):3608-16. |
Tuberculosis inhibitor 12
CAS: 793729-44-9 F: C15H9FN4O3S W: 344.32
Tuberculosis inhibitor 12 (compound 12) is an oxadiazole derivative and an inhibitor of Mycobacterium tuberculosis. The
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.